Bellerophon Therapeutics, Inc. (12)
Browse by Contract Category
Contracts
-
Form of Restricted Sock Unit Agreement under 2015 Equity Incentive Plan
(Filed With SEC on January 28, 2022)
-
Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
(Filed With SEC on March 11, 2021)
-
Underwriting Agreement by and between Bellerophon Therapeutics, Inc. and Jefferies LLC, dated May 18, 2020
(Filed With SEC on May 20, 2020)
-
Advisory Agreement, by and between Bellerophon Therapeutics, Inc. and Angel Pond Capital LLC, dated May 18, 2020
(Filed With SEC on May 20, 2020)
-
Open Market Sale AgreementSM, dated July 17, 2020, by and between Bellerophon Therapeutics, Inc. and Jefferies LLC
(Filed With SEC on July 17, 2020)
-
Subscription Agreement by and between Bellerophon Therapeutics, Inc. and Puissance Life Science Opportunities Fund VI, dated May 18, 2020
(Filed With SEC on May 20, 2020)
-
Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
(Filed With SEC on April 6, 2020)
-
Form of Engagement Letter
(Filed With SEC on March 30, 2020)
-
Form of Securities Purchase Agreement, dated as of March 30, 2020, by and among Bellerophon Therapeutics, Inc. and the Investors
(Filed With SEC on March 30, 2020)
-
Binding Term Sheet and Agreement for Line of Credit Facility dated December 16, 2019 between the Company and the signatories identified therein
(Filed With SEC on December 17, 2019)
-
Form of Warrant Amendment, dated June 28, 2019
(Filed With SEC on July 1, 2019)
-
Underwriting Agreement, dated January 23, 2019, by and between Bellerophon Therapeutics, Inc. and H.C. Wainwright & Co
(Filed With SEC on January 23, 2019)